MARC Record from marc_columbia

LEADER: 02290fam a2200433 a 4500
001 4051184
005 20221027024709.0
008 950804t19961996nyua b 001 0 eng c
010 $a 95038361
020 $a0896403017 (New York)
020 $a4260143018 (Tokyo)
035 $a(OCoLC)33077268
035 $a(OCoLC)ocm33077268
035 $9ALK3471HS
035 $a(NNC)4051184
035 $a4051184
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB-B
050 00 $aRC268.4$b.R67 1996
060 10 $aQZ 200 R824d 1996
082 00 $a616.99/407$220
100 1 $aRoss, Jeffrey S.$q(Jeffrey Stuart),$d1945-$0http://id.loc.gov/authorities/names/n95802560
245 10 $aDNA ploidy and cell cycle analysis in pathology /$cJeffrey S. Ross.
260 $aNew York :$bIgaku-Shoin,$c[1996], ©1996.
300 $axi, 156 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tBackground, basic principles, and techniques --$gCh. 2.$tQuantitative determination of total DNA content in human neoplasms: Technical considerations --$gCh. 3.$tClinical applications of DNA ploidy and cell cycle analysis: Role in cancer diagnosis and diagnostic cytopathology --$gCh. 4.$tDNA ploidy and cell cycle analysis: Prediction of tumor aggressiveness and clinical outcome --$gCh. 5.$tPractical issues in DNA ploidy and cell cycle analysis.
650 0 $aCancer$xGenetic aspects.$0http://id.loc.gov/authorities/subjects/sh85019509
650 0 $aDNA$xAnalysis.$0http://id.loc.gov/authorities/subjects/sh2008117525
650 0 $aCancer$xCytodiagnosis.$0http://id.loc.gov/authorities/subjects/sh89001678
650 0 $aChromosome numbers.$0http://id.loc.gov/authorities/subjects/sh85025387
650 0 $aCell cycle.$0http://id.loc.gov/authorities/subjects/sh85021643
650 12 $aDNA, Neoplasm$xanalysis.$0https://id.nlm.nih.gov/mesh/D004273Q000032
650 22 $aPloidies.$0https://id.nlm.nih.gov/mesh/D011003
650 22 $aCell Cycle.$0https://id.nlm.nih.gov/mesh/D002453
650 22 $aNeoplasms$xdiagnosis.$0https://id.nlm.nih.gov/mesh/D009369Q000175
650 22 $aNeoplasms$xgenetics.$0https://id.nlm.nih.gov/mesh/D009369Q000235
852 00 $boff,hsl$hRC268.4$i.R67 1996